ASM and CLSI Release White Paper on MSSA and Ceftriaxone Etests
The PSAB Committee on Laboratory Practices and the Clinical Laboratory Standards Institute (CLSI) have prepared MSSA and Ceftriaxone Etest issue: CLSI & ASM White Paper to discuss claims in a retracted paper that 60% of methicillin sensitive S. aureus (MSSA) isolates were resistant to ceftriaxone using Etest strips. The document reports the results of side by side testing of MSSA isolates with Etest strips versus reference broth microdilution.
The ASM has compiled a summary of recent Dual Use/Biosafety Research Policy responses.
- February 21, 2013 – U.S. Government Releases Proposed Policy for Dual Use Research of Concern
- October 17, 2012 - CDC Requests Comments Concerning Highly Pathogenic Avian Influenza (HPAI) H5N1
- September 17, 2012 - Revision of the NIH Guidelines to Include Synthetic Nucleic Acids and Clarification of Criteria for Section III-A-1-a Experiments
- Research Issues